Cambridge Investment Research Advisors
BSTC

Cambridge Investment Research Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,680
Closed -$670K – 2812
2020
Q3 		$670K Buy
12,680
+220
+2% +$13.6K ﹤0.01% 1423
2020
Q2 		$764K Sell
12,460
-3,617
-22% -$209K 0.01% 1291
2020
Q1 		$909K Buy
16,077
+1,958
+14% +$112K 0.01% 1018
2019
Q4 		$804K Buy
+14,119
New +$748K 0.01% 1283

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cambridge Investment Research Advisors's BSTC Position: Q4 2020 in Review

Cambridge Investment Research Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 12,680 shares — an estimated $670K sold.

Cambridge Investment Research Advisors first reported a position in BSTC in Q4 2019 and held it in 4 quarters. The position peaked at $909K in Q1 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Cambridge Investment Research Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 12,680 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $670K.
  • Cambridge Investment Research Advisors first reported a position in BioSpecifics Technologies Corp. in Q4 2019 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's BioSpecifics Technologies Corp. position peaked at $909K in Q1 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.